Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Clinical trial NCT00066443 · COMPLETED
Trial details
- NCT number
- NCT00066443
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-03
- Primary completion
- 2010-01-06
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.